BioPharma Credit (LON:BPCP) Sets New 52-Week High – Still a Buy?

BioPharma Credit PLC (LON:BPCPGet Free Report)’s share price hit a new 52-week high during mid-day trading on Thursday . The company traded as high as GBX 70.90 and last traded at GBX 70.90, with a volume of 357588 shares traded. The stock had previously closed at GBX 67.90.

BioPharma Credit Price Performance

The firm has a market capitalization of £974.12 million, a PE ratio of 10.47 and a beta of 0.22. The firm has a fifty day moving average price of GBX 67.73 and a 200 day moving average price of GBX 67.60.

About BioPharma Credit

(Get Free Report)

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. BioPharma Credit PLC was incorporated in 2016 and is based in London, the United Kingdom.

See Also

Receive News & Ratings for BioPharma Credit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioPharma Credit and related companies with MarketBeat.com's FREE daily email newsletter.